,i #aagth ,,congress #ast ,session ,h4 ,r4 #agc ,,in ,,the ,,house ,,of ,,representatives ,january #d1 #bjba,ms4 ,velzquez 7for herself1 ,ms4 ,dean1 ,mr4 ,nadler1 ,mr4 ,sean ,patrick ,maloney of ,new ,york1 ,ms4 ,meng1 and ,mr4 ,sires7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend the ,public ,health ,service ,act to authorize the ,secretary to make grants and enter into cooperative agreements with entities to expand and support activities with respect to the prevention and treatment of a covered condition1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,,covid-#ai ,prevention and ,awareness ,act of #bjba4 #b4 ,,covid-#ai prevention and awareness grants ,subpart ,i of part ,d of title ,,iii of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bed;b et seq47 is amended by adding at the end the following3 #ccj,n4 ,program to prevent and treat covered conditions 7a7 ,in general ,the ,secretary1 acting through the ,director of the ,centers for ,disease ,control and ,prevention1 may award grants and enter into cooperative agreements with covered entities to expand and support activities with respect to the prevention and treatment of covered conditions1 including-- 7#a7 conducting screenings1 surveillance1 and diagnostic testing for covered conditions2 7#b7 providing guidance to individuals on such prevention and treatment activities2 and 7#c7 providing guidance on vaccinations recommended by the ,advisory ,committee on ,immunization ,practices established by the ,secretary4 7b7 ,application ,an entity seeking a grant under this section shall submit an application to the ,secretary at such time1 in such manner1 and accompanied by such information as the ,secretary may require4 7c7 ,priority ,in awarding grants or entering into cooperative agreements under this section1 the ,secretary shall give priority to-- 7#a7 federally qualified health centers 7as defined in section #ccj;,a72 7#b7 community-based organizations2 and 7#c7 entities that have an agreement with a federally-qualified health center4 7d7 ,reports 7#a7 ,report to ,secretary ,an entity that receives a grant or enters into a cooperative agreement under this section shall submit to the ,secretary a report that includes-- 7,a7 a description of each activity carried out-- 7i7 pursuant to the cooperative agreement2 or 7ii7 with amounts received through the grant2 and 7,b7 an evaluation of the effectiveness of each such activity4 7#b7 ,report to ,congress ,not later than #c years after the date of the enactment of this section1 the ,secretary shall submit to ,congress a report on the effectiveness of the grants and cooperative agreements entered into under this section4 7e7 ,supplement not supplant ,an entity receiving a grant under this section shall use grant amounts to supplement1 not supplant1 any other ,federal1 ,state1 and local funds that would otherwise be expended by such entity to carry out the activities described in this section4 7f7 ,definitions ,in this section3 7#a7 ,covered condition ,the term covered condition means a disease or condition that has been identified by the ,centers for ,disease ,control and ,prevention to increase1 or likely increase1 the risk of mortality from ,,covid-#ai or to increase1 or likely increase1 the risk of severe illness from ,,covid-#ai1 including the following3 7,a7 ,asthma4 7,b7 ,cancer4 7,c7 ,cerebrovascular disease4 7,d7 ,chronic kidney disease4 7,e7 ,chronic obstructive pulmonary disease4 7,f7 ,cystic fibrosis4 7,g7 ,hypertension or high blood pressure4 7,h7 ,liver disease4 7,i7 ,neurologic conditions1 including dementia4 7,j7 ,obesity4 7,k7 ,pregnancy4 7,l7 ,pulmonary fibrosis4 7,m7 ,serious heart conditions1 including heart failure1 coronary artery disease1 and cardiomyopathy4 7,n7 ,sickle cell disease4 7,o7 ,pulmonary conditions resulting from tobacco use4 7,p7 ,thalassemia4 7,q7 ,tobacco use4 7,r7 ,type #a and #b diabetes mellitus4 7,s7 ,weakened immune system1 including from-- 7i7 a solid organ transplant2 7ii7 a blood or bone marrow transplant2 7iii7 the human immunodeficiency virus2 and 7iv7 the use of a corticosteroid or other immune weakening medicine4 7#b7 ,covered entity ,the term covered entity includes the following3 7,a7 ,federally qualified health center 7as defined in section #ccj;,a74 7,b7 ,entity that has an agreement with a federally qualified health center4 7,c7 ,community-based organization4 7,d7 ,faith-based organization4 7,e7 ,nonprofit organization4 7g7 ,authorization of appropriations ,to carry out this section1 there is authorized to be appropriated #b1jjj1jjj1jjj for the period of fiscal years #bjba through #bjbb1 to remain available until expended4 #ccj,o4 ,grant program to increase awareness of the relationship between covered conditions and ,,covid-#ai 7a7 ,in general ,the ,secretary1 acting through the ,director of the ,centers for ,disease ,control and ,prevention1 may award grants to entities to carry out a campaign to increase awareness of the relationship between-- 7#a7 covered conditions2 and 7#b7 the increased risk of developing a severe illness or mortality from ,,covid-#ai4 7b7 ,application ,an entity seeking a grant under this section shall submit an application to the ,secretary at such time1 in such manner1 and accompanied by such information as the ,secretary may require1 including a description of how the entity intends to carry out the activities specified in subsection 7c74 7c7 ,campaign activities ,in carrying out the campaign under subsection 7a71 an entity shall-- 7#a7 develop and disseminate informational material-- 7,a7 that is culturally and linguistically appropriate2 7,b7 targeted toward communities and populations that are at a high risk of-- 7i7 developing a covered condition2 and 7ii7 contracting ,,covid-#ai2 7,c7 that increases awareness of the safety and effectiveness of a ,,covid-#ai vaccine2 and 7,d7 that identifies locations in the community served by the entity where ,,covid-#ai vaccines are administered2 7#b7 consult with members of such communities and populations to develop the informational material under paragraph 7#a72 and 7#c7 disseminate informational material on treatments available for covered conditions1 including1 if applicable1 treatments provided by the entity4 7d7 ,priority ,in awarding grants under this section1 the ,secretary shall give priority to-- 7#a7 federally qualified health centers 7as defined in section #ccj;,a72 7#b7 community-based organizations2 and 7#c7 entities that have an agreement with a federally qualified health center4 7e7 ,reports 7#a7 ,report to ,secretary ,an entity that receives a grant under this section shall submit to the ,secretary a report that includes-- 7,a7 a description of each activity carried out with amounts received through the grant2 and 7,b7 an evaluation of the effectiveness of each such activity4 7#b7 ,report to ,congress ,not later than #c years after the date of the enactment of this section1 the ,secretary shall submit to ,congress a report on the effectiveness of the grants entered into under this section4 7f7 ,supplement not supplant ,an entity receiving a grant under this section shall use grant amounts to supplement1 not supplant1 any other ,federal1 ,state1 and local funds that would otherwise be expended by such entity to carry out the activities described in this section4 7g7 ,definitions ,in this section3 7#a7 ,covered condition ,the term covered condition has the meaning given such term in section #ccj,n4 7#b7 ,,covid-#ai vaccine ,the term ,,covid-#ai vaccine means a vaccine that is intended to prevent1 mitigate1 or treat the virus that causes ,,covid-#ai and-- 7,a7 is licensed under section #cea of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bfb72 or 7,b7 authorized under section #efd of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;bbb-#c74 7h7 ,authorization of appropriations ,to carry out this section1 there is authorized to be appropriated #abj1jjj1jjj for the period of fiscal years #bjba through #bjbb1 to remain available until expended4 4